TherapeuticsMD TXMD
NASDAQ TXMD
$1.74 +0.06 (+3.57%)
At close: Nov 10, 2026 · 4:00 PM EST

TherapeuticsMD (TXMD) Net Short-Term Debt Issued (Repaid) (2011 - 2020)

Updated

Analysis

TherapeuticsMD (TXMD) Net Short-Term Debt Issued (Repaid) (2011 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net ST Debt (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -5.28 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.28 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -499.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -682.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -87.00 Mn
10 TherapeuticsMD 20.14 Mn -12.07 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 50.00 Mn
Jun 30, 2013 -100,000.00
Mar 31, 2013 -400,000.00
Sep 30, 2012 1.80 Mn
Jun 30, 2012 4.50 Mn
Mar 31, 2012 2.40 Mn
Dec 31, 2011 -1.70 Mn
Sep 30, 2011 1.35 Mn
Jun 30, 2011 382,905.00
Mar 31, 2011 267,244.00
API Access

TherapeuticsMD Net Short-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=TXMD&period=max&api_key=YOUR_API_KEY